Rosa M. Alves
Asst. Dean, Global Compliance, Seton Hall Law School
[email protected]|973-642-8382
PROGRAM SCHEDULED for May 13-15, 2025| Virtual
All times are listed in Eastern Time.
10:50 - 12:05
A Look Inside the Department of Justice’s Evaluation of Effective Compliance Programs Guidance
Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
Joshua L. Haber
Chief of the Criminal Division, U.S. Attorney’s Office for the District of New Jersey
Daniel Kahn
Partner, Davis Polk
Matthew Galvin
Co-Founder, Gentic Global Advisors PLLC
12:05 - 1:05
Lunch Break
1:05 - 2:25
Implementation of and Demonstrating Adherence to the Guidance
Gary Giampetruzzi
Partner, Litigation Department, Paul Hastings, LLP
Jonathan Mehta
Assistant General Counsel, Litigation & Investigations – Asia Pacific & North America,
Johnson & Johnson
Joseph Philipose
SVP, Chief Ethics & Compliance Officer, Emergent Biosolutions, Inc.
Keith M. McGahan
Board of Directors, WiNK Therapeutics, Chief Legal Officer, ALG Senior, and General Counsel & Chief Compliance Officer, Nouveau Biosciences
2:25 - 2:40
Break
2:40 - 5:00
Risk Assessment Discussion and Case Study:
9:30 - 11:00
The New Business Ethics and Compliance Function
Piergiorgio Pepe
President, Quantum Ethics
Lawrence Platkin
VP & Head, U.S. Office of Compliance (Retired), Bayer U.S. LLC
Signe Elbaek
Chief Compliance Officer, Mölnlycke Health Care AB (Denmark)
Moderator: Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
11:00 - 11:15
Break
11:15 - 12:45
12:45 - 1:45
Lunch Break
3:30 - 4:15
Virtual Networking Reception for All Program Faculty & Attendees
10:00 - 11:30
Compliance and Ethical Enterprise Leadership
11:45 - 12:45
Lunch Break
12:45 - 1:45
Deep Dive into Internal Investigations
1:45 - 2:00
Break
3:45 - 4:00
Conclusion & Closing Remarks
